John Kilichowski
Stock Analyst at Wells Fargo
(1.62)
# 2,930
Out of 4,670 analysts
7
Total ratings
40%
Success rate
0.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Kilichowski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADC Agree Realty | Maintains: Overweight | $80 → $79 | $76.45 | +3.34% | 2 | Nov 4, 2024 | |
| FVR FrontView REIT | Initiates: Overweight | $22 | $18.71 | +17.58% | 1 | Oct 28, 2024 | |
| NNN NNN REIT | Assumes: Equal-Weight | $47 → $50 | $43.66 | +14.52% | 1 | Oct 1, 2024 | |
| VTR Ventas | Assumes: Overweight | $61 → $71 | $63.55 | +11.72% | 1 | Oct 1, 2024 | |
| SBRA Sabra Health Care REIT | Assumes: Overweight | $16 → $20 | $18.41 | +8.64% | 1 | Oct 1, 2024 | |
| NHI National Health Investors | Assumes: Equal-Weight | $81 → $86 | $77.71 | +10.67% | 1 | Oct 1, 2024 |
Agree Realty
Nov 4, 2024
Maintains: Overweight
Price Target: $80 → $79
Current: $76.45
Upside: +3.34%
FrontView REIT
Oct 28, 2024
Initiates: Overweight
Price Target: $22
Current: $18.71
Upside: +17.58%
NNN REIT
Oct 1, 2024
Assumes: Equal-Weight
Price Target: $47 → $50
Current: $43.66
Upside: +14.52%
Ventas
Oct 1, 2024
Assumes: Overweight
Price Target: $61 → $71
Current: $63.55
Upside: +11.72%
Sabra Health Care REIT
Oct 1, 2024
Assumes: Overweight
Price Target: $16 → $20
Current: $18.41
Upside: +8.64%
National Health Investors
Oct 1, 2024
Assumes: Equal-Weight
Price Target: $81 → $86
Current: $77.71
Upside: +10.67%